Rex, Nathaniel http://orcid.org/0000-0003-3028-1336
Oueidat, Karim
Ospel, Johanna
McDonough, Rosalie
Rinkel, Leon
Baird, Grayson L.
Collins, Scott
Jindal, Gaurav
Alvin, Matthew D.
Boxerman, Jerrold
Barber, Phil
Jayaraman, Mahesh
Smith, Wendy
Amirault-Capuano, Amanda
Hill, Michael
Goyal, Mayank
McTaggart, Ryan
Article History
Received: 11 August 2023
Accepted: 10 January 2024
First Online: 26 January 2024
Declarations
:
: This study was approved by the Rhode Island Hospital Institutional Review Board. This study was performed in line with the principles of the Declaration of Helsinki.
: After review by the IRB, the need for informed consent was waived due to the retrospective nature of this study.
: Nathaniel Rex does not report any conflicts of interest.Karim Oueidat does not report any conflicts of interest.Johanna Ospel does not report any conflicts of interest.Rosalie McDonough does not report any conflicts of interest.Leon Rinkel does not report any conflicts of interest.Grayson Baird does not report any conflicts of interest.Scott Collins does not report any conflicts of interest.Gaurav Jindal does not report any conflicts of interest.Matthew Alvin does not report any conflicts of interest.Jerrold Boxerman does not report any conflicts of interest.Phil Barber does not report any conflicts of interest.Mahesh Jayaraman does not report any conflicts of interest.Wendy Smith does not report any conflicts of interest.Amanda Amirault-Capuano does not report any conflicts of interest.Michael Hill reports grants from Canadian Institutes for Health Research, Alberta Innovates, and NoNO, for the conduct of the study; reports personal fees from Merck; reports non-financial support from Hoffmann-La Roche Canada; reports grants from Covidien (Medtronic), Boehringer-Ingleheim, Stryker, and Medtronic, outside the submitted work; reports a patent for systems and methods for assisting in decision-making and triaging for acute stroke patients, issued to US Patent office Number 62/086,077; owns stock in Calgary Scientific; is a director of the Canadian Federation of Neurological Sciences and Circle NeuroVascular; and has received grant support from Alberta Innovates Health Solutions, CIHR, Heart & Stroke Foundation of Canada, and the National Institutes of Neurological Disorders and Stroke. CGM holds stock from NoNO.Mayank Goyal reports personal fees from Medtronic, Stryker, Microvention, and Mentice, during the conduct of the study; unrestricted research grants to University of Calgary from NoNO, Stryker, and Medtronic; patents for a system of acute stroke diagnosis, with royalties paid to GE Healthcare, and a system of simulation for acute neurointervention, with royalties paid to Mentice; and ownership interest in Circle Neurovascular.Ryan McTaggart does not report any conflicts of interest.